Poly Medicure Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Poly Medicure Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every ₹100 of sales, ₹44 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹30 tied up three years earlier. More money tied up than 85% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹80Over the last 3 years, every ₹100 of reported profit came with ₹80 of operating cash.
Lower than 73% of Healthcare companies in India.
Self-Funding Ratio
0.8×Over the last 3 years its own operating cash paid for 81% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 70% of Healthcare companies in India.
Cash Locked Ratio
₹44For every ₹100 of sales, ₹44 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹30 tied up three years earlier.
More money tied up than 85% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹20Sales grew 69% in 3 years; of every extra ₹100 of sales, ₹20 became extra profit.
Higher than 58% of Healthcare companies in India.
Asset Productivity Ratio
+69% / +148%In 3 years sales changed by +69% while total assets changed by +148%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.9×Debt due within a year is covered 0.9 times by its yearly operating cash.
Lower than 58% of Healthcare companies in India.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Higher than 76% of Healthcare companies in India.
Tangible Assets Ratio
89%Of every ₹100 the company owns, ₹89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 73% of Healthcare companies in India.
Tangible Net Worth Ratio
86%Of every ₹100 of net worth, ₹86 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 67% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Poly Medicure Limited owes ₹0.20 for every ₹1 it owns. Net profit fell 2% in the year to Mar 2026, and grew 23% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
46.5Investors pay ₹46.5 for every ₹1 of Poly Medicure Limited's yearly profit, higher than 66% of Healthcare companies in India.
P/B ratio
4.71The share price is 4.71 times Poly Medicure Limited's book value per share, higher than 51% of Healthcare companies in India.
Market cap
₹14,637 CrThe total market value of all of Poly Medicure Limited's shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹3,106 CrWhat Poly Medicure Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹306.45Net worth divided by the number of shares. The share price of ₹1,444 is 4.7 times this, which is the P/B above.
Return on equity (ROE)
10.1%Poly Medicure Limited earned 10.1% on its shareholders' money over the last year, lower than 65% of Healthcare companies in India.
Owes vs Owns
0.20×Poly Medicure Limited owes ₹0.20 for every ₹1 it owns (low), lower than 83% of Healthcare companies in India.
Dividend yield
0.22%Poly Medicure Limited pays 0.22% of its share price as dividends a year, lower than 69% of dividend-paying Healthcare companies in India.
Revenue growth
+12%Revenue rose 12% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Profit growth
-2%Net profit fell 2% in the year to Mar 2026, and grew 23% a year on average over 3 years.
Profit margin
17.7%Poly Medicure Limited keeps ₹18 of every ₹100 of revenue as net profit.
Cash quality
0.7×Cash from Poly Medicure Limited's business was 0.7× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
17.9×Poly Medicure Limited's operating profit covered its interest costs 17.9 times in the year to Mar 2026.
Cash vs debt
Net cashPoly Medicure Limited held ₹519 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Poly Medicure Limited's P/E ratio?
Investors pay ₹46.5 for every ₹1 of Poly Medicure Limited's yearly profit, higher than 66% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Poly Medicure Limited: ₹14,637 Cr ÷ ₹3,106 Cr (31 Mar 2026) = 4.7.
What is Poly Medicure Limited's return on equity?
Poly Medicure Limited earned 10.1% on its shareholders' money over the last year, lower than 65% of Healthcare companies in India.
How much does Poly Medicure Limited owe compared with what it owns?
Poly Medicure Limited owes ₹0.20 for every ₹1 it owns (low), lower than 83% of Healthcare companies in India.
Does Poly Medicure Limited pay a dividend?
Yes. Poly Medicure Limited pays 0.22% of its share price as dividends a year, lower than 69% of dividend-paying Healthcare companies in India.
Is Poly Medicure Limited's revenue growing?
Revenue rose 12% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.